Depression is a widespread mental health problem, affecting about 264 million people. According to WHO, depression is the primary cause of disability globally and a substantial source of global disease burden. Researchers from Washington University School of Medicine in St. Louis and the University of Chicago have observed that a single, one-hour treatment with the inhalation of a blend of oxygen and the sedative drug nitrous oxide (NO), also known as laughing gas, can benefit patients with depression resistant to medication or therapy. The findings of phase II clinical study were reported in the journal Science Translational Medicine.
Researchers also observed that the efficacy of 25% NO concentration was equal to a 50% NO concentration and also reduced the likelihood of side effects. How does NO work? NO is a gas that and has been used in anesthesiology for a long time. It has been a…
